Clinical Trial Update: Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial Overgrowth [Phase 4]

View source ↗

Summary

Phase 4 trial assessing efficacy and safety of Saccharomyces boulardii for irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Saccharomyces boulardii (Saccharomyces boulardii)

Snippet

Sponsor: Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED